These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10200903)

  • 1. Fertility-sparing treatment of patients with ovarian cancer.
    McHale MT; DiSaia PJ
    Compr Ther; 1999 Mar; 25(3):144-50. PubMed ID: 10200903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
    Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
    J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman.
    Kammerer-Doak D; Baurick K; Black W; Barbo DM; Smith HO
    Gynecol Oncol; 1996 Oct; 63(1):133-7. PubMed ID: 8898183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
    Li J; Wu X
    Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wedge resection of the opposite ovary in conservative surgery of malignant ovarian tumor: is there any value?].
    Kotera K; Moriyama S; Ishimaru T; Nakajima H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():527-30. PubMed ID: 15535301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
    Kindermann G; Maassen V; Kuhn W
    Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary.
    Palenzuela G; Martin E; Meunier A; Beuzeboc P; Laurence V; Orbach D; Frappaz D
    Ann Surg; 2008 Nov; 248(5):836-41. PubMed ID: 18948812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is fertility sparing surgery a treatment option for premenopausal patients with dysgerminoma?
    Iavazzo C; Vorgias G; Iavazzo PE; Gkegkes ID
    Bratisl Lek Listy; 2016; 117(12):738-740. PubMed ID: 28127973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing treatment of patients with ovarian cancer.
    DiSaia PJ
    Compr Ther; 1990 Nov; 16(11):35-42. PubMed ID: 2269014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminoma.
    Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldfarb M; Nuchtern JG; Langer M; Vasudevan SA; Doski JJ; Goldin AB; Raval M; Beierle EA
    J Surg Res; 2018 Apr; 224():38-43. PubMed ID: 29506849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases.
    Wu PC; Huang RL; Lang JH; Huang HF; Lian LJ; Tang MY
    Gynecol Oncol; 1991 Jan; 40(1):2-6. PubMed ID: 1846603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fertility-sparing surgery in borderline ovarian tumours].
    Pehlivanov B; Iamakov K; Ivancheva H
    Akush Ginekol (Sofiia); 2015; 54(1):21-6. PubMed ID: 25909126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian malignancies in childhood and adolescence.
    Major T; Borsos A; Lampé L; Juhász B
    Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):65-8. PubMed ID: 8674568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ovarian malignant germ cell tumors with preservation of fertility.
    Long L; Jiang P; Liu FZ; Wang XP; Zhao TJ
    Chin Med J (Engl); 1993 Apr; 106(4):303-6. PubMed ID: 8325159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
    Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.